Total Valuation
XORTX Therapeutics Inc has a market cap or net worth of €1.49M. The enterprise value is 2.52M.
Market Cap€1.49M
Enterprise Value2.52M
Share Statistics
XORTX Therapeutics Inc has 1,816,565 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,816,565
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
XORTX Therapeutics Inc’s return on equity (ROE) is -1.28 and return on invested capital (ROIC) is -153.74%.
Return on Equity (ROE)-1.28
Return on Assets (ROA)-0.99
Return on Invested Capital (ROIC)-153.74%
Return on Capital Employed (ROCE)-1.56
Revenue Per Employee0.00
Profits Per Employee-1.35M
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of XORTX Therapeutics Inc is ―. XORTX Therapeutics Inc’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio1.28
Price to FCF-0.94
Price to Operating Cash Flow-0.30
PEG Ratio0.02
Income Statement
In the last 12 months, XORTX Therapeutics Inc had revenue of 0.00 and earned -2.66M in profits. Earnings per share was -2.80.
Revenue0.00
Gross Profit0.00
Operating Income-3.26M
Pretax Income-2.66M
Net Income-2.66M
EBITDA-3.14M
Earnings Per Share (EPS)-2.80
Cash Flow
In the last 12 months, operating cash flow was -5.00M and capital expenditures 3.14M, giving a free cash flow of -1.87M billion.
Operating Cash Flow-5.00M
Free Cash Flow-1.87M
Free Cash Flow per Share-1.03
Dividends & Yields
XORTX Therapeutics Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.97
52-Week Price Change-68.93%
50-Day Moving Average1.55
200-Day Moving Average1.73
Relative Strength Index (RSI)32.97
Average Volume (3m)125.00
Important Dates
XORTX Therapeutics Inc upcoming earnings date is Nov 12, 2026, TBA (Confirmed).
Last Earnings DateAug 15, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
XORTX Therapeutics Inc as a current ratio of 1.61, with Debt / Equity ratio of 0.00%
Current Ratio1.61
Quick Ratio1.61
Debt to Market Cap0.01
Net Debt to EBITDA0.26
Interest Coverage Ratio0.00
Taxes
In the past 12 months, XORTX Therapeutics Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
XORTX Therapeutics Inc EV to EBITDA ratio is -0.58, with an EV/FCF ratio of -0.65.
EV to Sales0.00
EV to EBITDA-0.58
EV to Free Cash Flow-0.65
EV to Operating Cash Flow-0.65
Balance Sheet
XORTX Therapeutics Inc has €992.85K in cash and marketable securities with €0.00 in debt, giving a net cash position of €992.85K billion.
Cash & Marketable Securities€992.85K
Total Debt€0.00
Net Cash€992.85K
Net Cash Per Share€0.55
Tangible Book Value Per Share€2.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for XORTX Therapeutics Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast4.18%